Summary The prognostic significance of tumour cell proliferation was investigated in a series of 418 gastric carcinomas using the monoclonal antibody MIB-1. Owing to strong intratumoural heterogeneity of MIB-1 expression three different proliferation indices (PIs) were determined in all carcinomas: (1) PImax in areas of maximal tumour cell proliferation, (2) PIrand in areas randomly distributed over the whole tumour, (3) Plfront in areas exclusively located at the tumour invasion front. There was a strong intertumoral heterogeneity with 
High proliferative activity has been shown to correlate with poor clinical outcome in a variety of human malignancies such as breast cancer (Tubiana et al., 1989; Gasparini et al., 1992a; Aaltomaa et al., 1993; Siitonen et al., 1993; Railo et al., 1993; Haerslev and Jacobsen, 1994) , colon cancer (Alsheneber et al., 1993; Mayer et al., 1993) , lung cancer (Fujii et al., 1993) , bladder cancer (Skopelitou et al., 1992; Lipponen et al., 1992; Mulder et al., 1992) , prostatic cancer (Harper et al., 1992) or ovarian cancer (Isola et al., 1990; Jordan et al., 1993; Kerns et al., 1994; Henriksen et al., 1994; Thomas et al., 1995) . Nevertheless, studies lacking such a correlation between tumour cell proliferation and prognosis have also been reported in the same tumour entities (Hemming et al., 1992; Kubota et al., 1992; Gasparini et al., 1992b; Cummings et al., 1993; Thomas et al., 1993) .
Investigations on tumour cell proliferation have also been carried out in gastric cancer (Yonemura et al., 1990a (Yonemura et al., ,b, 1991 (Yonemura et al., , 1993 Porschen et al., 1991; Jain et al., 1991; Kakeji et al., 1991; Mori et al., 1993) , only some of which have also focused on its prognostic role. Whereas Yonemura et al. (1990a) as well as Mori et al. (1993) stressed the proliferative activity as an independent prognostic parameter in gastric cancer, Jain et al. (1991) failed to show this correlation. A positive correlation shown in another study (Yonemura et al., 1993) was limited to biopsy material of advanced gastric cancers and could not be confirmed by multivariate analysis. Finally, in another study on gastric carcinomas tumour cell proliferation was shown to be correlated with a worse prognosis (Maeda et al., 1995) , but there was a strong predominance of late-stage tumours with serosal infiltration in this study.
Most of these investigations are immunohistochemical studies using antibodies against the Ki-67 antigen or the proliferating cell nuclear antigen (PCNA). The Ki-67 antigen is present in all stages of the cell cycle except Go (Gerdes et al., 1984) and the Ki-67 antibody is the most reliable antibody for assessing the growth fraction by immunohistochemistry (Brown and Gatter, 1990; Quinn and Wright 1990) . However, it only works on cryostat sections, thus limiting its application in routine pathology and archival paraffin blocks. The PCNA antibody has the advantage of working on formalin-fixed and paraffin-embedded sections, however, PCNA expression is not only associated with DNA synthesis, but also dependent on other factors, e.g. its synthesis can be induced by various growth factors (Bravo, 1986; Macdonald-Bravo and Bravo, 1985) . Recently, a novel antibody (MIB-1) was generated against the Ki-67 antigen, which is suitable for paraffin sections after microwave processing. Thus, MIB-1 combines the advantages of the Ki-67 and PCNA antibodies, being a reliable marker of proliferation for easy assessment of the growth fraction on paraffin-embedded tissue Cattoretti et al., 1992) . Owing to the contradictory results concerning gastric carcinoma, we investigated the prognostic role of tumour cell proliferation in a large retrospective series of 418 gastric cancer patients using the monoclonal antibody MIB-1.
Material and methods Patients
The present study is based on 529 consecutive patients undergoing potentially curative surgery for gastric cancer from January 1980 to December 1988. Curative surgery was defined as the removal of all gross tumours and the demonstration of tumour-negative surgical margins by microscopic examination of the total circumference of the gastric resection line (RO resection). Total gastrectomy was performed in 315 patients (59.5%), subtotal resection in 214 patients (40.5%), 327 patients (61.8%) were male and 202 (38.2%) were female. The mean age was 64.9 years ranging from 23 to 90 years. Follow-up letters were sent to the surgeons or local tumour registers to obtain up-to-date information on survival and relapse or death. Twenty-one per cent of the patients were lost to follow-up, leaving 418 patients for the final study and statistical evaluation. None of the patients received adjuvant chemotherapy. In order to eliminate bias due to deaths directly resulting from operation, patients who died within 4 weeks after surgery were excluded from the survival analysis.
Pathological review
The surgical specimens were fixed in formalin overnight at room temperature and embedded in paraffin. An average of four sections per tumour was prepared and the paraffin sections were routinely stained with haematoxylin eosin (HE) and periodic acid Schiff reaction (PAS). All sections were reviewed without knowledge of the clinical outcome. The histological type of the tumour was determined according to the WHO classification (Oota and Sobin, 1977) and the Lauren classification (Lauren, 1965) . To compare the prognostic significance of the proliferative activity as determined by MIB-1 expression with known prognostic parameters, the following morphological features were recorded: depth of invasion (pT category; International Union Against Cancer, Hermanek and Sobin, 1987) , lymph node involvement (pN category), grade of tumour differentiation as well as blood vessel invasion (BVI) and lymphatic vessel (LVI) invasion (Gabbert et al., 1991) . Tissue for a pathohistological verification of distant metastasis (pM category) could only be obtained in 23 out of the 418 patients, so this parameter was excluded from further evaluation.
Immunohistochemistry
From each patient one representative tumour block including tumour centre and invasion front as well as tumourassociated non-neoplastic mucosa were examined by immunohistochemistry. In cases of large late-stage tumours (pT3 and pT4) different sections were examined to include representative areas from the tumour centre as well as from the lateral and deep tumour invasion front. The formaldehyde-fixed paraffin sections were stained for MIB-1 using the avidin -biotin complex (ABC) technique after microwave pretreatment, three times for 5 min at 600 W (citrate buffer, pH 6.0). The primary antibody was diluted 1:10 with phosphate-buffered saline (PBS) and the slides were then counterstained with haemalaune.
Tonsils and lymph nodes from separate paraffin blocks were used as positive controls. Additionally, MIB-1 staining in adjacent non-neoplastic gastric mucosa present in all of the investigated tumour blocks served as a further internal positive control. Negative controls were performed by replacing the primary antibody through PBS. All slices were evaluated without knowledge of the clinical outcome.
MIB-1 -positive cells showed a distinct brown staining of the nuclei with a strong intratumoral heterogeneity ( Figure 1 ). Only nuclear staining was accepted as positive and all labelled tumour cell nuclei were regarded as positive. No differences could be found in staining intensity when tumours from 1980 to 84 and those from 1985 to 88 were compared, thus excluding a possible influence of ageing on the stored materials.
Proliferation index (PI)
The MIB-l proliferation index (PI) was calculated as the percentage of MIB-l-positive tumour cell nuclei determined in at least ten high-power fields (HPFs) by counting at least 1000 tumour cells. All tumour cell counts were made at 400 x magnification using a 10 x 10 mm square grid that had been placed in the eyepiece.
Owing to the strong intratumoral heterogeneity of tumour cell proliferation three different proliferation indices were defined ( Figure 2 ). (1) PI maximum (PIm,,,) was determined in at least ten HPFs suggested to have the highest labelling index when the tumour was prescored at low magnification.
(2) PI random (PIrand) was evaluated in at least ten HPFs chosen at random. (3) PIfront was determined in at least ten HPFs exclusively located at the lateral or deep invasion front of the tumours.
The median value of each of the three different PI values was used as a cut-off value to discriminate between tumours with a high PI ( > median PI) and those with a low PI (< median PI).
Statistical analysis
Tests for differences between the groups with a high and low PI were performed using Fisher's exact test for dichotomous variables, the chi-square test for other categorical variables and the Wilcoxon-Mann-Whitney test for ordinal variables. Analyses of survival were performed using the KaplanMeier method (Kaplan and Meier, 1958) and differences between the patient groups were tested by the log-rank test (Kalbfleisch and Prentice, 1980) . Differences with P-values <0.05 were considered as significant.
Results
The activity of tumour cell proliferation strongly differed between individual tumours, the lowest PI in a tumour being 3.4%, the highest 92.2% (Table I) . Furthermore, there was a strong intratumoral heterogeneity of tumour cell proliferation, the mean values of the proliferation indices being 51.3% in areas of maximal proliferation, 34.2% in randomly selected areas and 37.2% in areas at the tumour invasion front.
In the non-neoplastic gastric mucosa adjacent to the tumour, MIB-1 expression was only detected in a few cells of the proliferation zone at the neck of the gastric glands. Correlation with other histopathological parameters With regard to the Lauren classification (Table II) (Table II) .
In contrast, no significant correlation was observed when tumour cell proliferation was correlated with depth of invasion (pT category), lymph node involvement (pN category), stage of disease (UICC classification) or grade of tumour differentiation (Table II) .
Concerning blood vessel invasion (BVI) and lymphatic vessel invasion (LVI) a positive correlation was found for the PI determined at the invasion front of the tumours (P=0.001 and P = 0.002 respectively), but not for Plma, and PIrand. Thus, tumours with a higher tumour cell proliferation at the invasion front significantly more often showed blood vessel invasion and lymphatic vessel invasion than those with a low PI (Table III) .
Survival analysis
As shown by the log-rank test no significant differences in the survival rates exist between tumours with PIs higher than the Time (years) Figure 3 Survival curves of 418 gastric cancer patients. No statistically significant differences between tumours with maximum proliferative activity (Plmax) higher and lower than the median value.
tumours (Table V) . The same was true for the pN category. Among the 418 patients included in this investigation, the 189 lymph node-negative patients had a significantly better prognosis than the 229 lymph node-positive patients (P= 0.0001). Tumour cell proliferation, however, had no influence on survival in the subgroup of lymph node-negative patients or in that of lymph node-positive patients (Table  VI) .
Discussion
The proliferation rate of tumours has long been considered to reflect the course and prognosis of tumour disease. Various methods have been described and, besides the mitotic count, immunohistochemical assessment of the growth fraction seems to be the easiest method for routine pathology. The monoclonal Ki-67 antibody has been shown to be a most reliable marker of cell proliferative activity, however, its use is limited to frozen tissue sections (Brown and Gatter, 1990 al., 1993) . In the present study on 418 gastric carcinomas a similar heterogeneity became evident with a PI ranging from 3% to 92% proliferating tumour cells in different carcinomas. Furthermore, a conspicious intratumoral heterogeneity was found with a mean proliferative activity of 51.3% in areas of maximum proliferation in contrast to 34.2% in areas randomly selected over the tumour and 37.2% in areas located at the tumour invasion front. This heterogeneity may represent true clonal subpopulations of tumour cells that have accquired a growth advantage. However, it cannot be ruled out that this heterogeneity is only temporary, depending on local factors such as growth factors that may influence the activity of tumour cell proliferation. Thus, this strong intratumoral heterogeneity limits the evaluation of tumour cell proliferation in gastric biopsies.
Concerning the correlation of tumour cell proliferation with clinicopathological parameters, contradictory results have been reported in gastric cancer using either Ki-67 (Yonemura et al., 1990a , b, 1991 Kakeji et al., 1991; Porschen et al., 1991) or PCNA (Jain et al., 1991; Mori et al., 1993; Yonemura et al., 1993; Maeda et al., 1995) . In the present study we were able to show a statistically significant correlation between tumour cell proliferation and histological tumour type according to the Lauren classification. Thus, tumours with a glandular appearance of the so-called intestinal type showed significantly higher PI values than carcinomas of the diffuse type. Similarly, the papillary and tubular carcinomas of the WHO classification showed a statistically significant higher PI value than signet-ring cell carcinomas. In other studies on gastric cancer, tumour cell proliferation was not correlated with the WHO classification but with the Lauren classification in the studies of Jain et al.
(1991) as well as Mori et al. (1993) . In both of these studies, using the PCNA antibody, the intestinal-type carcinomas also had a higher growth fraction than the diffuse-type carcinomas, although the difference did not reach statistical significance. Furthermore, it was shown that in experimentally induced colon carcinomas also, the undifferentiated tumours exhibited a statistically significant lower tumour cell proliferation than differentiated gland-building tumours (Gabbert et al., 1982 findings are in accordance with those of some other studies using Ki-67 (Yonemura et al., 1990a; b, 1991) , a positive correlation between a high PI and pT category was also reported using Ki-67 (Kakeji et al., 1991) or PCNA (Mori et al., 1993; Yonemura et al., 1993) , whereas Jain et al. (1991) reported a higher tumour cell proliferation index in lower pT categories using PCNA. In our study a statistically significant correlation was found between tumour cell proliferation at the invasion front and the presence of blood or lymphatic vessel invasion, which has been shown in the same population of patients to be important prognostic factors in gastric carcinomas (Gabbert et al., 1991) . This result is consistent with several of the previous studies also reporting a positive correlation between vascular invasion and a high proliferative activity for Ki-67 (Yonemura et al., 1991; Kakeji et al., 1991) and PCNA (Mori et al., 1993) . Nevertheless, we could not find a significantly higher percentage of lymph node metastases in the tumours with a high proliferative activity.
Accordingly, no impact of tumour cell proliferation on survival could be verified in our study. Although this lack of prognostic significance of tumour cell proliferation was true (PIa., PId, PIfr00t) investigated in our study. there is a contrast to some previous studies showing a correlation between high tumour cell proliferation and poor prognosis in univariate analysis using PCNA (Yonemura et al.. 1993 ) and in multivarate analysis using Ki-67 (Yonemura et al., 1990a) or PCNA (Mon et al.. 1993; Maeda et al.. 1995) . These studies. however. included only small numbers of patients and were in part limited to advanced carcinomas. most of them with serosal infiltration (Yonemura et al.. 1990a : Maeda et al.. 1995 . To consider this aspect of our study the prognostic impact of tumour cell proliferation was separately analysed in the subgroup of pT1 and pT2 tumours and in the subgroup of advanced pT3 and pT4 tumours as well as in nodenegative and node-positive patients. A statistically significant impact of tumour cell proliferation on survival could be verified in none of these subgroups, however.
Looking at the literature, tumour cell proliferation has been shown to be an independent prognostic parameter in gastric cancer in three studies. each comprising about 90 cases of gastric carcinoma. The reasons why our study on 418 gastnc carcinomas could not confirm this finding can only be speculative, but tissue fixation. different antibodies and different methods of evaluating the proliferating tumour cells are known to influence the assessment of tumour cell proliferation as a prognostic marker. Furthermore, the cell cycle time, which cannot be measured by MIB-1 immunohistochemistry, might be more important for biological behaviour than the pure growth fraction of tumour cells. As a main result from our study. it seems reasonable. however, that. at least in gastric cancer, the factors that lead to more aggressive tumour growth with early recurrence or metastases are not related to the growth fraction as determined by immunohistochemical methods alone.
In summary, according to the results of the present retrospective study. the immunohistochemiical detection of MIB-1 is a valuable tool for evaluating proliferative activity in formalin-fixed tumour tissue. Nevertheless, in our series of 418 gastric carcinomas, tumour cell proliferation had no impact on the prognosis; neither was it a useful tool for defining subgroups of patients who may be at a higher risk. Our retrospective study may. nevertheless, encourage further investigations under prospective conditions.
